Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Virginia G. Piper Cancer Center Stories

2013-05-09 08:31:27

X16 Phone Makes Mother's Day Debut, Proceeds Benefit the Virginia G. Piper Cancer Center at Scottsdale Healthcare SCOTTSDALE, Ariz., May 9, 2013 /PRNewswire/ -- Communication is crucial in the fight against breast cancer and XBLUE Networks has the perfect pink telephone to do just that. (Photo: http://photos.prnewswire.com/prnh/20130509/PH10677-a ) (Photo: http://photos.prnewswire.com/prnh/20130509/PH10677LOGO-b ) Making its debut this Mother's Day, the Pink X16 special...

2013-01-23 10:47:37

Virginia G. Piper Cancer Center data presented at San Francisco ASCO symposium A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. The MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study was led by physicians from Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials, a...

2013-01-22 20:21:01

Virginia G. Piper Cancer Center data presented at San Francisco ASCO symposium SCOTTSDALE, Ariz., Jan. 22, 2013 /PRNewswire-USNewswire/ -- A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. (Photo: http://photos.prnewswire.com/prnh/20120201/DC45876) The MPACT (Metastatic Pancreatic...

2012-11-16 12:26:32

Phase III study results show improvement in overall survival compared to standard treatment SCOTTSDALE, Ariz., Nov. 16, 2012 /PRNewswire-USNewswire/ -- A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the...

2012-09-26 06:24:43

Go Daddy Donates $10,000 for Scottsdale Healthcare Cancer Center Fundraiser SCOTTSDALE, Ariz., Sept. 26, 2012 /PRNewswire-USNewswire/ -- GoDaddy.com, the world's largest provider[1] of Web hosting and domain name registrations, is donating $10,000 to help cancer patients and kick-start fundraising for the 4(th) annual Scottsdale Healthcare Rob Moy Memorial Motorcycle Run. The Nov. 3 event is a fundraiser for the Gift of Life Lodging Program at the Virginia G. Piper Cancer Center at...

2012-08-29 10:23:18

In the news release, New Virginia G. Piper Cancer Center-TGen study targets small-cell lung cancer, issued 29-Aug-2012 by Scottsdale Healthcare over PR Newswire, we are advised by the company that the headline should read "New Virginia G. Piper Cancer Center-TGen study targets non-small cell lung cancer" rather than "New Virginia G. Piper Cancer Center-TGen study targets small-cell lung cancer" as originally issued inadvertently. The complete, corrected release follows: New Virginia G. Piper...

2012-08-29 10:23:03

PR610 designed to activate in cancer tissue with low levels of oxygen SCOTTSDALE, Ariz., Aug. 29, 2012 /PRNewswire-USNewswire/ -- A Phase I/II, multi-center trial designed to test the safety and preliminary efficacy of a first-in-class cancer treatment opened worldwide today at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). PR610 is designed to...

2012-08-23 10:23:57

Primetime fundraising event to air Sept. 7 simultaneously on ABC, CBS, FOX, NBC and cable channels SCOTTSDALE, Ariz., Aug. 23, 2012 /PRNewswire-USNewswire/ -- Physicians and staff from the Virginia G. Piper Cancer Center at Scottsdale Healthcare will mingle with Hollywood A-listers during the live, primetime television broadcast of the Stand Up To Cancer (SU2C) fundraising telethon on Sept. 7. (Logo: http://photos.prnewswire.com/prnh/20120823/DC62223LOGO ) Virginia G. Piper Cancer...

2012-06-13 10:00:30

World's first patient treated at Virginia G. Piper Cancer Center by Scottsdale Healthcare, TGen physicians; follow-up study led by Mayo Clinic-TGen physician proved key to early FDA approval of vismodegib Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New...

2012-04-03 09:06:45

SU2C-funded study is the first to evaluate treatment based on molecular profiling of advanced pancreatic cancer The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare. The findings were announced during the American Association for Cancer Research...